Skip to main content
Industry News
Compound unmasks tumor cells in mice

A compound that mimics the structure of genetic material present in some viruses improved the efficacy of existing immunotherapies in mouse models of human melanoma, according to a study in Science Translational Medicine. The compound, which is now in human trials, makes tumor cells that have stopped producing antigens recognizable to the immune system.

Full Story: